home / stock / allk / allk news

ALLK News and Press, Allakos Inc. From 08/02/23

Stock Information
Company Name: Allakos Inc.
Stock Symbol: ALLK
Market: NASDAQ
Website: allakos.com
Menu
ALLK ALLK Quote ALLK Short ALLK News ALLK Articles ALLK Message Board
Get ALLK Alerts

News, Short Squeeze, Breakout and More Instantly...
ALLK - Allakos Appoints Rand Sutherland and Dolca Thomas to its Board of Directors

SAN CARLOS, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases, today announced ...
ALLK - Allakos Presents Preclinical Data at EAACI Hybrid Congress 2023 Highlighting Lirentelimab and AK006 Mechanisms of Mast Cell Inhibition

– AK006 inhibits IgE mediated mast cell activation and shows similar IgE inhibitory activity as remibrutinib – – AK006 also inhibits non-IgE mast cell activation pathways, including KIT-mediated activation– SAN CARLOS, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- Al...

ALLK - Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023

SAN CARLOS, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases, today announced ...

ALLK - Why Allakos Stock Skyrocketed Nearly 9% Higher Today

2023-05-12 17:00:53 ET Allakos (NASDAQ: ALLK) finished the trading week in style, with its stock price climbing by just under 9% on Friday. That was largely due to an analyst recommendation upgrade, which, in turn, was encouraged by strong quarterly results posted by the company. In...
ALLK - Allakos gains as Jefferies upgrades to Buy on lead candidate

2023-05-12 09:15:18 ET Allakos ( NASDAQ: ALLK ) rose ~8% pre-market Friday after Jefferies upgraded the immunology-focused biotech to Buy from Hold, citing an attractive risk-reward setup ahead of a Phase 2 readout for its lead candidate lirentelimab. San Carlos, California-...

ALLK - Allakos GAAP EPS of -$0.49

2023-05-09 17:56:54 ET Allakos press release ( NASDAQ: ALLK ): Q1 GAAP EPS of -$0.49. For further details see: Allakos GAAP EPS of -$0.49

ALLK - Allakos Provides Business Update and Reports First Quarter 2023 Financial Results

SAN CARLOS, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for...
ALLK - FROG, TPIC and SGH are among after hour movers

2023-04-10 17:30:11 ET Gainers: Nogin ( NOGN ) +18% . Allakos ( ALLK ) +5% . TPI Composites ( TPIC ) +5% . SMART Global Holdings ( SGH ) +3% . PriceSmart ( PSMT ) +3% . Losers: NVIDIA  ( NVDA ) -26% . Kur...

ALLK - Why Allakos Stock Was Heating Up Today

2023-03-07 16:05:58 ET Shares of the clinical-stage biopharma Allakos (NASDAQ: ALLK) defied the turbulence in the broader markets today. Specifically, the drugmaker's shares were up by a healthy 21% on heavy volume at Tuesday's close. The big gain came in response to the company...

ALLK - CARA and DOMO among mid-day movers

2023-03-07 12:39:41 ET Gainers: ThredUp ( TDUP ) +73% . WW International ( WW ) +49% . Unicycive ( UNCY ) +39% . Protagonist Therapeutics ( PTGX ) +32% . Bionomics ( BNOX ) +28% . Novo Integrated Sciences ( NVOS ) +25% ...
Previous 10 Next 10